Herduo 250 mg Tablets (containing the active ingredient Lapatinib I.P.) are a targeted anti-cancer medication prescribed for the treatment of advanced or metastatic HER2-positive …
Herduo 250 mg Tablets (containing the active ingredient Lapatinib I.P.) are a targeted anti-cancer medication prescribed for the treatment of advanced or metastatic HER2-positive breast cancer. Manufactured by Natco Pharma, it works by inhibiting the overproduction of EGFR and HER2 proteins to slow or stop cancer cell growth.
liketo.usa,uk,china,southkorea,russia,japan,singapore
Packaging Size 30 Tablets
Strength 250 mg
Pack Size 30 Tablets
Form Tablet
Usage HER2+ Breast Ca, Breast Cancer
Manufactured By Natco
Country of Origin Made in India
Composition Lapatinib Tablets IP
Brand Herduo
Packaging Type Box
Treatment Breast cancer
Minimum order quantity: 50 Bottle
Composition details not available.
We offer reliable delivery across India and international markets. Domestic orders typically arrive within 5–7 business days. International shipping times vary by destination. All orders are carefully packaged to maintain product integrity and quality.
